Covestor’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1K Hold
4
– – ﹤0.01% 2114
2026
Q2
$1K Buy
4
+1
+33% +$172 ﹤0.01% 2193
2026
Q1
$1K Sell
3
-1
-25% -$171 ﹤0.01% 2057
2025
Q4
$1K Hold
4
– – ﹤0.01% 2075
2025
Q3
$1K Hold
4
– – ﹤0.01% 2096
2025
Q2
$1K Buy
+4
New +$491 ﹤0.01% 2012
2024
Q1
– Sell
-4
Closed -$546 – 2455
2023
Q4
$1K Buy
+4
New +$488 ﹤0.01% 1979
2023
Q3
– Sell
-11
Closed -$1K – 2362
2023
Q2
$1K Sell
11
-2
-15% -$260 ﹤0.01% 1959
2023
Q1
$2K Hold
13
– – ﹤0.01% 1757
2022
Q4
$2K Hold
13
– – ﹤0.01% 1778
2022
Q3
$2K Hold
13
– – ﹤0.01% 1712
2022
Q2
$2K Hold
13
– – ﹤0.01% 1614
2022
Q1
$2K Sell
13
-10
-43% -$1.3K ﹤0.01% 1674
2021
Q4
$4K Buy
+23
New +$3.56K 0.01% 1394

Other funds holding IBB

Covestor's IBB Position: Q3 2026 in Review

Covestor held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 4 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

Covestor first reported a position in IBB in Q4 2021 and has held it in 14 quarters since. The position peaked at $4K in Q4 2021. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Covestor held 4 shares of iShares Biotechnology ETF worth $1K as of Q3 2026.
  • Covestor left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2114 holding.
  • Covestor first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 14 quarters since.
  • Covestor's iShares Biotechnology ETF position peaked at $4K in Q4 2021.
  • 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.